GlaxoSmithKline to become more proficient in warding off bacterial infections with the purchase.
Ebola has killed more than 8,200 people. Companies like J&J are getting closer to a treatment.
Britain's biggest companies are set to lavish 85.3 billion pounds on their shareholders in 2015.
A group of 20 volunteers developed immunity to the Ebola virus and showed no bad side effects.
Why are there no treatments for Ebola? The economics of medical research are partly to blame.
Human trials for the treatment candidates are already under way, and another five drugs will begin clinical trials next year.
The U.K.’s biggest drugmaker announced big plans for cost-cutting and its HIV research arm on Wednesday.
There are two Ebola vaccines currently in clinical trials.
Investors are still making bets on biotech firms researching Ebola.
A look at the experimental drugs and vaccines that may bring an end to the deadly outbreak.
America's first Ebola patient, Thomas Eric Duncan, died while being treated with a drug from a relatively unknown biotech company.
The company is already investigating alleged bribery in a number of Middle East countries, as well as Poland.
Some stocks jumped more than 20 percent in just one hour.
The British company's executives involved in the bribery case received suspended prison sentences on Friday.
GSK could ultimately face a multi-million dollar settlement payment or fine.
The current Ebola outbreak, which particularly affected West Africa, has so far claimed 1,427 lives in four countries. A cure for the virus is yet to be discovered.